treatment
Guinan, Eva
Pediatric Hematologist-Oncologist
Dana-Farber Cancer Institute
Online Profile:
Vikas, Gupta, MD, FRCP, FRCPath
Gupta, Vikas
Oncologist Hematologist
University of Toronto
Majed M. Abuhajir, MD
Abuhajir, Majed
Hematology Oncologist
Christus Health
Jayastu Senapati, MBBS, MD, DM
Senapati, Jayastu
The University of Texas MD Anderson Cancer Center
Online Profile:
Anurag Singh, MD
Singh, Anurag
Associate Professor, Hematologic Malignancies and Cellular Therapeutics
The University of Kansas
Dr. Singh completed his Internal Medicine Residency as well as his Hematology and Oncology Fellowship at the State University of New York Upstate Medical University. His clinical interests include mismatched donor stem cell transplantation , Hereditary predisposition to hematologic malignancies and Cellular therapies. His research interests include donor selection in stem cell transplantation, Transplantation for myeloid malignancies , GVHD prophylaxis and germline predisposition to Hematological malignancies
Online Profile:
AAMDSIF Calls for Restoration of Bone Marrow Failure Research Funding
High Risk MDS - 2025 Kansas City Patient and Family Conference
In this recording, Dr. Jesus Gonazlez Lugo discusses the diagnosis of High Risk MDS and the evolution to AML along with treatment options for patients. Recording includes the question-and-answer session.
Aplastic Anemia - 2025 Kansas City Patient and Family Conference
Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients
Pre-transplant inflammation and its associations with acute GvHD and mortality in pediatric allogeneic hematopoietic stem cell transplantation patients
Abstract